Levodopa-Carbidopa intestinal gel may prove more effective for long-term treatment of Parkinson’s disease than standard Levodopa

26 febrero 2015

Data from one-year trial on long-term safety, efficacy, and quality of life in advanced Parkinson’s disease patients using levodopa-carbidopa intestinal gel has been released by researchers, suggesting that it may be an effective long term treatment for the illness.